How much to invest in glycemic control of a patient with diabetes mellitus type 2? A constant dilemma for the Brazilian Public Health System (SUS). Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 55, p. e17197, 2019. DOI: 10.1590/s2175-97902019000117197. Disponível em: https://revistas.usp.br/bjps/article/view/164524.. Acesso em: 2 apr. 2025.